Exabis Library
Welcome to the e-CCO Library!
P655 Pharmacokinetics of ustekinumab in children and adolescents with moderately to severely active Crohn’s disease: Results from UniStar, a phase 1 study
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P655: A study to determine factors affecting clinical decision making in outpatients with inflammatory bowel disease
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P655: Early life mebendazole exposure increases the risk of adult-onset ulcerative colitis: a population-based cohort study
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P655: Immunogenicity after transition from adalimumab to ABP 501 in patients with plaque psoriasis
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P655: Insulin Resistance Prevalence is Not Increased in Patients with Inflammatory Bowel Disease: a case-control study
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P655: MadCAM1 Negativity of Lamina Propria Endothelial Cells is Associated with Non-Response to Vedolizumab in Inflammatory Bowel Disease Patients
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM
P655: Microencapsulated Sodium Butyrate significantly modifies the microbiota in patients with inflammatory bowel disease mimicking prebiotic activity and proving effects on the treatment of the disease
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P656 Clinical implications of endoscopic submucosal dissection in management of patients with ulcerative colitis-associated dysplasia
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P656: Are trough levels of anti-TNF drugs related with treatment failure and duration of treatment?
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P656: Epidemiology and outcomes associated with local surgical and intersphincteric ligation procedures for complex cryptoglandular fistulas: A systematic literature review
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P656: Is there a role for additional oral mesalamine therapy in the treatment of ulcerative proctitis with skip inflammation?
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P656: Malnutrition rates are highest in pre-surgical Crohn’s disease when compared with active CD, CD in remission and UC in remission
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P656: Superior treatment persistence with ustekinumab in biologic-experienced luminal Crohn's disease: real-world registry data from the Persistence Australian National IBD Cohort (PANIC) study
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM
P656: The impact of periodontitis on IBD disease activity
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P657 Evolution of Crohn’s disease progression and surgery rates over 10 years for patients who initiated biologic treatment early compared with late or no biologic initiation
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P657: Acceptability of a COVID-19 vaccine among cohort of Croatian IBD patients treated in tertiary IBD centre
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P657: Backwash ileitis not influences the risk of the pouchitis, but can increase the risk of the pouch dysplasia
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P657: Current landscape of the real-world utilization of Interleukins 22, 23 and Interleukin 22 binding protein as biomarkers for Inflammatory Bowel Disease (IBD): A targeted literature review
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM
P657: Persistence in smoking cessation in inflammatory bowel disease (IBD)
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P657: Postoperative outcome in Crohn’s disease: Observational study of 1283 surgical patients
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM